Andrew Fisher - May 15, 2025 Form 4/A - Amendment Insider Report for Verona Pharma plc (VRNA)

Role
General Counsel
Signature
/s/ Andrew Fisher
Stock symbol
VRNA
Transactions as of
May 15, 2025
Transactions value $
$160,904
Form type
4/A - Amendment
Date filed
6/18/2025, 04:30 PM
Date Of Original Report
May 16, 2025
Previous filing
May 1, 2025
Next filing
Jun 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fisher Andrew General Counsel 3 MORE LONDON, RIVERSIDE, LONDON, UNITED KINGDOM /s/ Andrew Fisher 2025-06-18 0002014301

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Options Exercise $161K +80K +22.22% $2.01 440K May 15, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRNA Share Options (Right to Buy) Options Exercise $0 -80K -3.33% $0.00 2.32M May 15, 2025 Ordinary Shares 80K $2.01 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the Reporting Person's Form 4 filed on May 16, 2025, which contained a typographical error in the price reported.
F2 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F3 The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer.
F4 The option vested and became exercisable as to 25% on March 4, 2025. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.